Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Haxby

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Health Affairs (Project Hope)|September 13, 2006
An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug PlanDaniel M Hartung, Kathy L Ketchum, Dean G Haxby
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Gabapentin use in a managed medicaid populationAnn M Hamer, Dean G Haxby, Bentson H McFarland, et al.
Systematic Reviews|April 16, 2015
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysisAmanda S Meeker, Megan C Herink, Dean G Haxby, et al.
Pharmacotherapy|September 28, 2005
Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control studyDaniel M Hartung, Daniel R Touchette, Nanette C Bultemeier, et al.
Family Medicine|March 5, 2009
Antimicrobial prescribing for upper respiratory infections and its effect on return visitsJohn Li, Anindya De, Kathy Ketchum, et al.
The Annals of Pharmacotherapy|May 17, 2007
Rates of adverse events of long-acting opioids in a state Medicaid programDaniel M Hartung, Luke Middleton, Dean G Haxby, et al.
Clinical Therapeutics|November 9, 2004
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid populationDaniel M Hartung, Daniel R Touchette, Kathy L Ketchum, et al.
Current Medical Research and Opinion|September 13, 2007
How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programsRobert J Valuck, Elaine H Morrato, Sheri Dodd, et al.
Clinical Therapeutics|March 24, 2007
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003Elaine H Morrato, Sheri Dodd, Gary Oderda, et al.
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid programAnn M Hamer, Daniel M Hartung, Dean G Haxby, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Affairs (Project Hope)|September 13, 2006
An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug PlanDaniel M Hartung, Kathy L Ketchum, Dean G Haxby
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Gabapentin use in a managed medicaid populationAnn M Hamer, Dean G Haxby, Bentson H McFarland, et al.
Systematic Reviews|April 16, 2015
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysisAmanda S Meeker, Megan C Herink, Dean G Haxby, et al.
Pharmacotherapy|September 28, 2005
Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control studyDaniel M Hartung, Daniel R Touchette, Nanette C Bultemeier, et al.
Family Medicine|March 5, 2009
Antimicrobial prescribing for upper respiratory infections and its effect on return visitsJohn Li, Anindya De, Kathy Ketchum, et al.
The Annals of Pharmacotherapy|May 17, 2007
Rates of adverse events of long-acting opioids in a state Medicaid programDaniel M Hartung, Luke Middleton, Dean G Haxby, et al.
Clinical Therapeutics|November 9, 2004
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid populationDaniel M Hartung, Daniel R Touchette, Kathy L Ketchum, et al.
Current Medical Research and Opinion|September 13, 2007
How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programsRobert J Valuck, Elaine H Morrato, Sheri Dodd, et al.
Clinical Therapeutics|March 24, 2007
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003Elaine H Morrato, Sheri Dodd, Gary Oderda, et al.
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid programAnn M Hamer, Daniel M Hartung, Dean G Haxby, et al.
Pageof 2